• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与出口部位及隧道感染相关的腹膜炎

Peritonitis associated with exit site and tunnel infections.

作者信息

Gupta B, Bernardini J, Piraino B

机构信息

Department of Medicine, University of Pittsburgh School of Medicine, PA 15213, USA.

出版信息

Am J Kidney Dis. 1996 Sep;28(3):415-9. doi: 10.1016/s0272-6386(96)90500-4.

DOI:10.1016/s0272-6386(96)90500-4
PMID:8804241
Abstract

We reviewed all episodes of peritonitis associated with exit site and/or tunnel infection (n = 87; rate, 0.1/yr; 13% of all peritonitis episodes) occurring from 1979 to 1995. The exit site or tunnel infection was diagnosed at the time or shortly after the patient presented with peritonitis in 66% of the episodes. In the other one third the exit site or tunnel infection was diagnosed a median of 40 days prior to the development of peritonitis. Staphylococcus aureus accounted for 52% of episodes. Pseudomonas aeruginosa was the next most common organism. In 63 (72%) of the episodes the catheter was removed to resolve the infection at a median of 8 days (range, 0 to 226 days) from the onset of peritonitis. Catheter removal after 5 days predominately for refractory peritonitis (n = 23; median time to removal, 8 days) or relapsing peritonitis (n = 11; median time to catheter removal, 103 days). Patients with relapsing peritonitis suffered two to four episodes prior to removal of the catheter. Patients with peritonitis associated with tunnel infection were more likely to lose their catheter than patients with peritonitis associated with exit site infection (86% v 58%), while Staphylococcus epidermidis infections were less likely to result in catheter loss compared with all other organisms (15% v 82%). After a protocol to reduce S aureus catheter infections was implemented in 1990, the rate of catheter-related peritonitis decreased from 0.14/yr to 0.05/yr due to a decrease in S aureus episodes. We conclude that peritonitis episodes associated with a tunnel infection infrequently resolve without catheter removal. Delayed catheter removal in such circumstances often results in refractory or relapsing peritonitis. Therefore, catheter removal should be done promptly. Antibiotic prophylaxis for S aureus can reduce catheter-related peritonitis.

摘要

我们回顾了1979年至1995年间发生的所有与出口部位和/或隧道感染相关的腹膜炎病例(n = 87;发生率为0.1/年;占所有腹膜炎病例的13%)。在66%的病例中,出口部位或隧道感染是在患者出现腹膜炎时或之后不久被诊断出来的。在另外三分之一的病例中,出口部位或隧道感染是在腹膜炎发生前中位时间40天被诊断出来的。金黄色葡萄球菌占病例的52%。铜绿假单胞菌是其次最常见的病原体。在63例(72%)病例中,为解决感染问题,在腹膜炎发作后中位时间8天(范围为0至226天)拔除了导管。5天后拔除导管主要是针对难治性腹膜炎(n = 23;拔除的中位时间为8天)或复发性腹膜炎(n = 11;导管拔除的中位时间为103天)。复发性腹膜炎患者在拔除导管前经历了两到四次发作。与出口部位感染相关的腹膜炎患者相比,与隧道感染相关的腹膜炎患者更有可能失去导管(86%对58%),而与所有其他病原体相比,表皮葡萄球菌感染导致导管丢失的可能性较小(15%对82%)。1990年实施减少金黄色葡萄球菌导管感染的方案后,由于金黄色葡萄球菌病例减少,导管相关腹膜炎的发生率从0.14/年降至0.05/年。我们得出结论,与隧道感染相关的腹膜炎病例很少在不拔除导管的情况下得到解决。在这种情况下延迟拔除导管通常会导致难治性或复发性腹膜炎。因此,应及时拔除导管。针对金黄色葡萄球菌的抗生素预防可减少导管相关腹膜炎。

相似文献

1
Peritonitis associated with exit site and tunnel infections.与出口部位及隧道感染相关的腹膜炎
Am J Kidney Dis. 1996 Sep;28(3):415-9. doi: 10.1016/s0272-6386(96)90500-4.
2
A five-year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis.一项关于持续性非卧床腹膜透析出口部位感染和腹膜炎微生物学结果的五年研究。
Am J Kidney Dis. 1987 Oct;10(4):281-6. doi: 10.1016/s0272-6386(87)80023-9.
3
The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.莫匹罗星预防腹膜透析导管相关感染中金黄色葡萄球菌的有效性。
Adv Perit Dial. 2000;16:257-61.
4
Analysis of continuous ambulatory peritoneal dialysis-related Pseudomonas aeruginosa infections.持续性非卧床腹膜透析相关铜绿假单胞菌感染的分析
Am J Med. 1987 Nov;83(5):829-32. doi: 10.1016/0002-9343(87)90638-3.
5
A comparison of infection rates among older and younger patients on continuous peritoneal dialysis.老年与年轻持续性腹膜透析患者感染率的比较。
Perit Dial Int. 1994;14(1):66-9.
6
Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.经皮导管翻修术治疗腹膜透析患者难治性出口部位感染/隧道感染:单中心经验。
Nephrology (Carlton). 2012 Nov;17(8):760-6. doi: 10.1111/j.1440-1797.2012.01644.x.
7
Frequent involvement of the internal cuff segment in CAPD peritonitis and exit-site infection - an ultrasound study.持续性非卧床腹膜透析相关性腹膜炎及出口处感染中内袖套段的频繁累及——一项超声研究
Nephrol Dial Transplant. 1996 Feb;11(2):336-9. doi: 10.1093/oxfordjournals.ndt.a027263.
8
Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.预防金黄色葡萄球菌携带对腹膜导管相关葡萄球菌感染发生率的影响。文献综述。
Perit Dial Int. 2001 Sep-Oct;21(5):471-9.
9
Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.腹膜导管出口处感染:易感因素、预防与治疗
Int J Artif Organs. 2003 Aug;26(8):698-714. doi: 10.1177/039139880302600802.
10
Determinants of catheter loss following continuous ambulatory peritoneal dialysis peritonitis.持续性非卧床腹膜透析相关性腹膜炎后导管丢失的决定因素。
Perit Dial Int. 2008 Jul-Aug;28(4):361-70.

引用本文的文献

1
Clinical and microbiological factors predicting outcomes of nonfermenting gram-negative bacilli peritonitis in peritoneal dialysis.预测腹膜透析中非发酵革兰阴性杆菌腹膜炎转归的临床和微生物学因素。
Sci Rep. 2021 Jun 10;11(1):12248. doi: 10.1038/s41598-021-91410-0.
2
The impact of the superficial cuff position on the exit site and tunnel infections in CAPD patients.腹透患者袖套出口处和隧道感染中外置短管位置的影响。
J Nephrol. 2021 Apr;34(2):493-501. doi: 10.1007/s40620-020-00788-z. Epub 2020 Jul 9.
3
Peritoneal Microbiome in End-Stage Renal Disease Patients and the Impact of Peritoneal Dialysis Therapy.
终末期肾病患者的腹膜微生物群及腹膜透析治疗的影响
Microorganisms. 2020 Jan 25;8(2):173. doi: 10.3390/microorganisms8020173.
4
Peritoneal dialysis (PD) catheter-related peritonitis from caused by poor caregiver's hand hygiene.因护理人员手部卫生不佳导致的腹膜透析(PD)导管相关性腹膜炎。
Med Mycol Case Rep. 2019 Jul 30;25:35-38. doi: 10.1016/j.mmcr.2019.07.005. eCollection 2019 Sep.
5
Clinical practice guidelines for the provision of renal service in Hong Kong: Infection Control in Renal Service.香港肾脏服务临床实践指南:肾脏服务中的感染控制
Nephrology (Carlton). 2019 Mar;24 Suppl 1(Suppl 1):98-129. doi: 10.1111/nep.13497.
6
Escherichia coli Peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center.腹膜透析患者的大肠埃希菌腹膜炎:中国南方一家透析中心的患病率、抗生素耐药性及临床结局
Perit Dial Int. 2014 May;34(3):308-16. doi: 10.3747/pdi.2013.00012. Epub 2014 Feb 4.
7
A qualitative systematic review of the literature supporting a causal relationship between exit-site infection and subsequent peritonitis in patients with end-stage renal disease treated with peritoneal dialysis.一项支持终末期肾病行腹膜透析患者出口部位感染与随后腹膜炎之间存在因果关系的文献的定性系统评价。
Perit Dial Int. 2013 Nov-Dec;33(6):604-10. doi: 10.3747/pdi.2012.00082.
8
Catheter-related peritonitis.导管相关腹膜炎
Perit Dial Int. 2013 Nov-Dec;33(6):592-5. doi: 10.3747/pdi.2013.00207.
9
Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis.氧氟沙星溶液用于腹膜透析中持续性出口处和隧道感染
Perit Dial Int. 2013 Jan-Feb;33(1):101-2. doi: 10.3747/pdi.2012.00070.
10
Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.小儿腹膜透析患者导管相关感染和腹膜炎预防与治疗的共识指南:2012年更新版
Perit Dial Int. 2012 Jun;32 Suppl 2(Suppl 2):S32-86. doi: 10.3747/pdi.2011.00091.